30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

George Golumbeski

Track

Insider profile

Currently holds positions in SAGE Therapeutics Inc, Enanta Pharmaceuticals Inc and MorphoSys AG

Performance

Overall performance
2.8
Performance over holding periods
2.8
30 days 90 days 120 days
Average return -0% 8.2% 15.1%
Success rate 56% 68% 82%
Transactions
4 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Director SAGE Therapeutics Inc Jan. 23, 2019 -
Independent Director Enanta Pharmaceuticals Inc Feb. 7, 2014 -
Independent Member of the Supervisory Board MorphoSys AG May 17, 2018 -
Independent Director Acceleron Pharma Inc Jan. 1, 2011 - June 6, 2018
George Golumbeski's trades of SAGE Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-05-09 2022-05-05
B Purchase
50,316 +23.2%
304.65
US$4,561,656 		50,316 +23.2% 304.65 US$4,561,656
2022-04-27 2022-04-26
B Purchase
52,724 -28.2%
496.67
US$1,020,090 		52,724 -28.2% 496.67 US$1,020,090
2022-04-26 2022-04-22
B Purchase
6,326 -10.3%
14.81
US$4,126,563 		6,326 -10.3% 14.81 US$4,126,563
2022-04-26 2022-04-21
B Purchase
26,049 +inf%
3.69
US$96,121 		26,049 +inf% 3.69 US$96,121
2019-03-06 2019-03-04
PlS Planned sale
9,280 -100.0%
103.65
US$961,897 		9,280 -100.0% 103.65 US$961,897
2019-02-13 2019-02-12
PlS Planned sale
11,228 -100.0%
90.07
US$1,011,301 		11,228 -100.0% 90.07 US$1,011,301
2019-02-13 2019-02-11
PlS Planned sale
2,272 -100.0%
90.03
US$204,552 		2,272 -100.0% 90.03 US$204,552